BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Neogyn Release: Sexual Dysfunction Common in Type II Diabetes Patients


1/22/2013 10:40:12 AM

NEW YORK, Jan. 22, 2013/PRNewswire/ -- According to Diabetes.org, 12.6 million women in America suffer from diabetes. Type II diabetes in particular is one of the most prevalent health concerns for women, affecting 95% of those diagnosedI. Despite the statistics, the side effects for women with diabetes often go undiscussed, one in particular being sexual dysfunction.

(Photo: http://photos.prnewswire.com/prnh/20120717/NY41829 )

Although research about sexual dysfunction in women with diabetes is limited, one study found 18 percent of women with type 1 diabetes and 42 percent of women with type 2 diabetes experience sexual dysfunction. II Autonomic neuropathy, damaged blood vessel, and a reduced blood flow are often to blame and can cause decreased lubrication and vulvar dryness as well as pain or discomfort during intercourse.

There are a variety of treatment options for diabetes; however, the sexual effects are often not addressed. To help moisturize and soothe the vulva, diabetic patients can use NeoGyn Vulvar Soothing Cream. The cream helps restore vulvar skin without estrogens. NeoGyn relies on a scientific formulation of cutaneous lysate, a novel ingredient discovered in Switzerland after years of wound healing research.

About Neogyn®:
Neogyn® Vulvar Soothing Cream is a cosmetic product to help soothe and comfort the vulva. Formulated with Cutaneous Lysate, a naturally balanced blend of proteins discovered in Switzerland, the product is non-greasy, fast absorbing and free of color additives, fragrances and analgesics. Recommended by physicians and women's health professionals, Neogyn® has a unique, patent pending blend of naturally balanced proteins that help restore well-being and comfort with twice daily use over a period of at least 6 to 8 weeks.

I. "The Facts About Diabetes: A Leading Cause of Death in the U.S." National Diabetes Education Program. National Diabetes Education Program, http://ndep.nih.gov/diabetes-facts/index.aspx#type

II. "Sexual and Urologic Problems of Diabetes." National Diabetes Information Clearinghouse (NDIC). National Diabetes Information Clearinghouse (NDIC), http://diabetes.niddk.nih.gov/dm/pubs/sup/index.aspx#women (accessed 2 Jan., 2013).

RELATED LINKS
http://www.neogyn.us

SOURCE NeoGyn



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES